3 European Stocks Estimated To Be Up To 49.8% Below Intrinsic Value

Simply Wall St

Fri, February 13, 2026 at 2:38 PM GMT+9 4 min read

In this article:

TLGO.MC

-1.37%

IVSO.ST

+27.52%

SNG.RO

+5.12%

GALDY

+0.98%

^GDAXI

-0.01%

As the European markets continue to show resilience amid global volatility, optimism about the eurozone economy has supported investor sentiment, with major indices like Germany’s DAX and France’s CAC 40 posting gains. In this environment of cautious optimism and stable interest rates from the European Central Bank, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential market opportunities.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Click here to see the full list of 199 stocks from our Undervalued European Stocks Based On Cash Flows screener.

We’re going to check out a few of the best picks from our screener tool.

SNGN Romgaz

Overview: SNGN Romgaz SA is engaged in the exploration, production, and supply of natural gas in Romania, with a market capitalization of RON44.32 billion.

Operations: The company’s revenue is primarily derived from its upstream operations, which account for RON7.85 billion, followed by storage services at RON614.59 million and electricity production at RON485.92 million.

Estimated Discount To Fair Value: 23.2%

SNGN Romgaz is trading at a value 23.2% below its estimated fair value and significantly under its future cash flow valuation of RON14.97, with current trading at RON11.5. Its earnings grew by 15.4% last year, and revenue growth is expected to outpace the regional market at 11.3% per year compared to 4.8%. Recent earnings showed increased net income for Q3 and nine months ending September 2025, indicating robust financial health despite high non-cash earnings levels.

Upon reviewing our latest growth report, SNGN Romgaz's projected financial performance appears quite optimistic.

Click here to discover the nuances of SNGN Romgaz with our detailed financial health report.

BVB:SNG Discounted Cash Flow as at Feb 2026

Invisio

Overview: Invisio AB (publ) develops and sells communication and hearing protection systems for defense, law enforcement, and security professionals globally, with a market cap of approximately SEK14.87 billion.

Operations: The company’s revenue primarily comes from the Aerospace & Defense segment, which generated SEK1.65 billion.

Story Continues  

Estimated Discount To Fair Value: 25.8%

Invisio is trading at SEK322, significantly below its estimated future cash flow value of SEK434.19, suggesting it may be undervalued. The company forecasts robust earnings growth of 44.3% annually over the next three years, outpacing the Swedish market’s 9.3%. Despite recent share price volatility, Invisio’s strategic management changes aim to enhance revenue growth and capitalize on market opportunities, potentially improving financial performance in a dynamic environment.

The analysis detailed in our Invisio growth report hints at robust future financial performance.

Delve into the full analysis health report here for a deeper understanding of Invisio.

OM:IVSO Discounted Cash Flow as at Feb 2026

Galderma Group

Overview: Galderma Group AG is a global dermatology company with a market cap of CHF35.73 billion.

Operations: The company generates revenue of $4.69 billion from its dermatology segment.

Estimated Discount To Fair Value: 49.8%

Galderma Group, trading at CHF150.5, is priced considerably below its estimated future cash flow value of CHF299.95, indicating potential undervaluation. The company has recently launched innovative products like Restylane Defyne and Refyne in Japan and received FDA acceptance for RelabotulinumtoxinA in the U.S., enhancing its aesthetic portfolio. Despite lower forecasted revenue growth compared to the broader market, Galderma’s earnings are expected to grow significantly at 26.9% annually over the next three years.

Insights from our recent growth report point to a promising forecast for Galderma Group's business outlook.

Navigate through the intricacies of Galderma Group with our comprehensive financial health report here.

SWX:GALD Discounted Cash Flow as at Feb 2026

Taking Advantage

Unlock our comprehensive list of 199 Undervalued European Stocks Based On Cash Flows by clicking here.

Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Contemplating Other Strategies?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include BVB:SNG OM:IVSO and SWX:GALD.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info